Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1-2
|
| pubmed:dateCreated |
1996-2-14
|
| pubmed:language |
swe
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0023-7205
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
3
|
| pubmed:volume |
93
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
16-7
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:8544524-Anti-Allergic Agents,
pubmed-meshheading:8544524-Anti-Asthmatic Agents,
pubmed-meshheading:8544524-Catalogs, Drug,
pubmed-meshheading:8544524-Dose-Response Relationship, Drug,
pubmed-meshheading:8544524-Drug Prescriptions,
pubmed-meshheading:8544524-Histamine H1 Antagonists,
pubmed-meshheading:8544524-Humans,
pubmed-meshheading:8544524-Sweden,
pubmed-meshheading:8544524-Terfenadine
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
[Important notice: normal dosage of Teldanex is halved].
|
| pubmed:publicationType |
Letter
|